Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Validation Study of ISOLD score in classifying Primary Vitreoretinal Lymphoma vs. Uveitis

David Kuo; Maggie Wei; H Nida Sen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):814. doi:

ARVO Annual Meeting Abstract June 2017

Anatomic distribution of IgG4-related disease in chronic orbital inflammatory lesions

David Kuo; Jeffrey Tsao; Ramzi Alameddine; Christina Di Loreto; Audrey Ko; Juan Rong; Vivian Snyder; Don Kikkawa; Bobby Korn; Jonathan Lin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1791. doi:

ARVO Annual Meeting Abstract September 2016

Differentiating Endophthalmitis from Uveitis and Vitreoretinal Lymphoma by Aqueous and Vitreous IL-6 and IL-10

David Kuo; Maggie M Wei; Karen R Armbrust; Ian Yeung; Chi-Chao Chan; Robert B Nussenblatt; H Nida Sen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3307. doi:

Immunology and Microbiology April 2016

Elevated CD1c + Myeloid Dendritic Cell Proportions Associate With Clinical Activity and Predict Disease Reactivation in Noninfectious Uveitis

PDF

Ping Chen; Cristhian A. Urzua; Jared E. Knickelbein; Jane S. Kim; Zhiyu Li; Susan Hannes; David Kuo; Benjamin Chaigne-Delalande; Karen Armbrust; William Tucker; Baoying Liu; Elvira Agrón; H. Nida Sen; Robert B. Nussenblatt
TAGS: dendritic cells, mdc protocol, uveitis
Invest. Ophthalmol. Vis. Sci.. 2016; 57(4):1765-1772. doi: https://doi.org/10.1167/iovs.15-18357

ARVO Annual Meeting Abstract April 2014

A Smartphone Application to Predict Post-DSAEK Refractive Shift

David Kuo; Richard Yi-Jen Hwang; Natalie A Afshari

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):872. doi:

Advertisement